BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 11030145)

  • 1. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.
    Engels IH; Stepczynska A; Stroh C; Lauber K; Berg C; Schwenzer R; Wajant H; Jänicke RU; Porter AG; Belka C; Gregor M; Schulze-Osthoff K; Wesselborg S
    Oncogene; 2000 Sep; 19(40):4563-73. PubMed ID: 11030145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
    Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis.
    Bantel H; Engels IH; Voelter W; Schulze-Osthoff K; Wesselborg S
    Cancer Res; 1999 May; 59(9):2083-90. PubMed ID: 10232592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis.
    Belka C; Rudner J; Wesselborg S; Stepczynska A; Marini P; Lepple-Wienhues A; Faltin H; Bamberg M; Budach W; Schulze-Osthoff K
    Oncogene; 2000 Feb; 19(9):1181-90. PubMed ID: 10713706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis.
    Perkins CL; Fang G; Kim CN; Bhalla KN
    Cancer Res; 2000 Mar; 60(6):1645-53. PubMed ID: 10749135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
    Poulaki V; Mitsiades N; Romero ME; Tsokos M
    Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
    Ozören N; El-Deiry WS
    Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
    Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells.
    Friesen C; Kiess Y; Debatin KM
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S73-85. PubMed ID: 15105835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells.
    Glaser T; Wagenknecht B; Weller M
    Oncogene; 2001 Aug; 20(35):4757-67. PubMed ID: 11521188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.
    von Haefen C; Wieder T; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
    Oncogene; 2003 Apr; 22(15):2236-47. PubMed ID: 12700660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells.
    You KR; Shin MN; Park RK; Lee SO; Kim DG
    Hepatology; 2001 Dec; 34(6):1119-27. PubMed ID: 11732001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
    Dirsch VM; Stuppner H; Vollmar AM
    Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadmium induces apoptotic cell death in WI 38 cells via caspase-dependent Bid cleavage and calpain-mediated mitochondrial Bax cleavage by Bcl-2-independent pathway.
    Oh SH; Lee BH; Lim SC
    Biochem Pharmacol; 2004 Nov; 68(9):1845-55. PubMed ID: 15450950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation.
    Stepczynska A; Lauber K; Engels IH; Janssen O; Kabelitz D; Wesselborg S; Schulze-Osthoff K
    Oncogene; 2001 Mar; 20(10):1193-202. PubMed ID: 11313863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
    Wang P; Song JH; Song DK; Zhang J; Hao C
    Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation.
    Boehrer S; Chow KU; Beske F; Kukoc-Zivojnov N; Puccetti E; Ruthardt M; Baum C; Rangnekar VM; Hoelzer D; Mitrou PS; Weidmann E
    Cancer Res; 2002 Mar; 62(6):1768-75. PubMed ID: 11912153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.